Compound Detail
CHEMBL3545181
TIOTROPIUM BROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
Basic Information
| ChEMBL ID | CHEMBL3545181 |
| Name | TIOTROPIUM BROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MQLXPRBEAHBZTK-SEINRUQRSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1900528 |
| Active Moiety | CHEMBL1900528 |
13
Targets
54
Activities
4
Assay Types
26
PK Parameters
20
Publications
13
Known Names
10
Indications
1
Mechanisms
Molecular Properties
392.5
MW (Da)
2.35
ALogP
6
HBA
1
HBD
59.1
PSA (Ų)
0.49
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2004 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Muscarinic acetylcholine receptor M3 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M3 | ✓ | ✓ |
Indications
Asthma Bronchial Spasm Bronchial Spasm Bronchitis, Chronic Emphysema Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Cystic Fibrosis Neoplasms Spinal Cord Injuries
ATC Classification
R03BB04
tiotropium bromide
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03BB54
tiotropium bromide, combinations
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
Ki 37 meas. best 11.0
IC50 14 meas. best 10.5
EC50 2 meas. best 9.4
Kd 1 meas. best 10.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 11.0 | 10.5535 | 0.0 | 17 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 10.89 | 9.7233 | 0.0 | 3 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 10.7 | 10.0383 | 0.0 | 6 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 10.58 | 9.745 | 0.0 | 2 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 10.5 | 9.746 | 0.0 | 5 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 10.5 | 10.0533 | 0.0 | 3 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 10.4 | 10.4 | 0.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 10.3 | 9.72 | 0.1 | 3 |
| Unchecked CHEMBL612545 | Kd | 10.1 | 10.1 | 0.1 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 10.0 | 10.0 | 0.1 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL309 | Ki | 9.82 | 9.82 | 0.1 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL276 | Ki | 9.8 | 9.8 | 0.2 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL320 | Ki | 9.52 | 9.52 | 0.3 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | EC50 | 9.4 | 8.82 | 0.4 | 2 |
| Muscarinic acetylcholine receptor M3 CHEMBL5498 | IC50 | 9.39 | 9.39 | 0.4 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 9.22 | 9.22 | 0.6 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 7.68 | 7.68 | 20.8 | 1 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 5.69 | 5.69 | 2058.7 | 1 |
| Translocator protein CHEMBL5742 | Ki | 5.37 | 5.37 | 4286.5 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 7.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 5.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | - | - | Homo sapiens |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | - |
| T1/2 | 24.0 | hr | Homo sapiens |
| T1/2 | 22.83 | hr | Homo sapiens |
| T1/2 | 23.83 | hr | Homo sapiens |
| T1/2 | 13.02 | hr | Homo sapiens |
| T1/2 | 24.0 | hr | Homo sapiens |
| T1/2 | 24.0 | hr | Homo sapiens |
| T1/2 | 9.452 | hr | - |
| T1/2 | 8.0 | hr | Cavia porcellus |
| t1/2 | - | - | Cavia porcellus |
| T1/2 | 12.5 | hr | Homo sapiens |
| T1/2 | 22.6 | hr | Homo sapiens |
| T1/2 | 20.1 | hr | Homo sapiens |
| T1/2 | 13.8 | hr | Homo sapiens |
| T1/2 | 12.4 | hr | Homo sapiens |
| T1/2 | 23.0 | hr | Homo sapiens |
| T1/2 | 31.7 | hr | Homo sapiens |
| T1/2 | 20.4 | hr | Homo sapiens |
| T1/2 | 25.4 | hr | Homo sapiens |
| T1/2 | 24.5 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24088171 | 10.1021/jm401219y | Muscarinic acetylcholine receptor M3 | 23 |
| 21870878 | 10.1021/jm200884j | Muscarinic acetylcholine receptor M3 | 9 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 8 |
| 24837158 | 10.1016/j.bmc.2014.04.031 | Rattus norvegicus | 7 |
| - | 10.6019/CHEMBL5058564 | U2OS | 7 |
| 32202101 | 10.1021/acs.jmedchem.0c00297 | Muscarinic acetylcholine receptor M3 | 6 |
| 19653626 | 10.1021/jm900132z | Plasma | 4 |
| 24144851 | 10.1016/j.bmcl.2013.09.092 | Cavia porcellus | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 3 |
| 19653626 | 10.1021/jm900132z | Cavia porcellus | 3 |
| 22047691 | 10.1016/j.bmcl.2011.10.002 | Cavia porcellus | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
| 21870878 | 10.1021/jm200884j | Muscarinic acetylcholine receptor M2 | 3 |
Data from ChEMBL 36 via Core Engine